◀ Back to EGF
EDN1 — EGF
Pathways - manually collected, often from reviews:
-
NCI Pathway Database EGFR-dependent Endothelin signaling events:
ETA receptor/Endothelin-1 complex (EDNRA-EDN1)
→
EGF (EGF)
(modification, activates)
Iwasaki et al., Endocrinology 1999, Cheng-Hsien et al., Pflugers Arch 2006*, Chen et al., Mol Pharmacol 2006*, Daub et al., Nature 1996, Iwasaki et al., J Cardiovasc Pharmacol 1998*
Evidence: mutant phenotype, other species
-
NCI Pathway Database EGFR-dependent Endothelin signaling events:
ETA receptor/Endothelin-1 complex (EDNRA-EDN1)
→
EGF/EGFR complex (EGF-EGFR)
(modification, activates)
Iwasaki et al., Endocrinology 1999, Cheng-Hsien et al., Pflugers Arch 2006*, Chen et al., Mol Pharmacol 2006*, Daub et al., Nature 1996, Iwasaki et al., J Cardiovasc Pharmacol 1998*
Evidence: mutant phenotype, other species
Text-mined interactions from Literome
Haug et al., J Cardiovasc Pharmacol 2000
:
Inhibitory
effect of
epidermal growth factor and hepatocyte growth factor on
endothelin-1 release by rabbit proximal tubule cells
Jia et al., Zhonghua Nan Ke Xue 2008
(Prostatic Neoplasms) :
To investigate the
effects of the
epidermal growth factor on the mRNA expression of
endothelin-1 and its receptors ( ET ( A ) R, ET ( B ) R ) in hormone refractory prostate cancer ( HRPC ) PC-3 cell lines
Chahdi et al., Cell Signal 2010
:
Endothelin-1 induces p66Shc activation through
EGF receptor transactivation : Role of beta ( 1 ) Pix/Galpha ( i3 ) interaction
Cybulsky et al., J Am Soc Nephrol 1993
:
Transforming growth factor-beta, complement C5b-9, thrombin, and phorbol myristate acetate significantly
enhanced endothelin-1 peptide synthesis in glomerular epithelial cells ( 45, 15, 55, and 25 % above basal levels at 24 h, respectively ), whereas
epidermal growth factor had no effect